Navigation Links
Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis

response (<50 percent improvement in PASI response relative to

baseline, with a minimum six point increase in PASI score compared to

week 33) compared to patients on placebo (28 percent).

-- In CHAMPION, a pivotal 16-week study evaluating 271 psoriasis patients

from eight European countries and Canada, HUMIRA-treated patients

experienced a significant reduction in the signs and symptoms of their

disease compared with methotrexate or placebo-treated patients, with

more than twice the percentage (80 percent) of patients treated with

HUMIRA achieving a PASI 75 response compared to patients treated with

methotrexate (36 percent), a standard systemic treatment for

psoriasis, and more than four times the percentage of patients treated

with placebo (19 percent).

Nearly 17 percent of patients treated with HUMIRA achieved a PASI 100

response at week 16, compared to 7 percent of patients receiving

methotrexate and 2 percent of patients receiving placebo. In

addition, a mean percentage PASI improvement of 57 percent was

achieved at week four in patients receiving HUMIRA, compared to


The most commonly reported adverse events in HUMIRA psoriasis trials were nasopharyngitis (inflammation of the nose and pharynx), upper respiratory tract infection and headache.

More Information About Psoriasis

Psoriasis is a chronic autoimmune disease that speeds the growth cycle of skin cells and results in thick scaly areas of skin. The most common form of psoriasis appears as red, raised areas of skin covered with flaky white scales, which may itch or burn. Psoriasis most commonly appears on the scalp, knees, elbows, lower back, hands and feet, though it can develop anywhere on the skin. It may even occur in the fingernails and toenails.

While psoriasis can occur in people of all ages, it typic

Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
5. IsoTis Receives FDA Clearance for Accell Family of Products
6. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
9. XTL Receives Staff Letter From NASDAQ
10. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
11. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
Post Your Comments:
(Date:8/28/2014)... 28, 2014  Next month, executives from clinical trial marketing ... events beginning with Patient-Centered Clinical Trials 2014 , to ... Boston , September 4-5. Patient recruitment experts Bonnie ... Fleishman will share insights on the benefits of employing ... tactics – from media to mobile apps – can be ...
(Date:8/28/2014)... , Aug. 28, 2014  Armetheon, Inc. ... developing novel mid- to late-stage cardiovascular drug candidates, ... in its first round of financing. The Series ... and Hercules Bioventures with participation from investors that ... pharmaceutical executive, Dr. Larry Hsu , the ...
(Date:8/28/2014)... Vt. (PRWEB) August 28, 2014 ... testing around the world is available from Strategic ... diagnostics companies. “ Industrial Microbiology Market Review, Fourth ... Industrial Market ” (IMMR—4) tracks and compares microbiology ... in North America, Europe and Asia, and forecasts ...
(Date:8/28/2014)... 2014 Supplementing their complete line ... for Eppendorf Safe Lock Centrifuge Tubes . ... highest quality tubes at an affordable price. Eppendorf ... doing chemical, medical, pharmaceutical, and life science research ... regularly able to afford Eppendorf products. , Eppendorf ...
Breaking Biology Technology:BBK Worldwide Leads Sessions at Key September Events 2Armetheon Completes $7.0 Million Series A Financing 2Armetheon Completes $7.0 Million Series A Financing 32 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor 2Eppendorf Safe Lock Centrifuge Tube Promotion Now Available at Major Pipette Distributor 3
... ShapeGrabber and Nikon,Instruments Inc. today announced ... a,sales distribution channel in the United States ... inspection systems. This arrangement will,increase ShapeGrabber,s current ... Nikon to provide customers with,additional non-contact solutions ...
... Mr. Stewart brings critical experience in strategic and operational leadership ... ... opportunities, COLUMBIA, Md., April 8, 2008 ... of the Company. Cylex is a,global life sciences company that develops ...
... Fla., April 8, 2008 GeoPharma, Inc.,(Nasdaq: ... today at the,EdgeWater Research Partners Spring Conference being ... 2:25 MT., "We are thoroughly pleased to ... President David Lavigne. "GeoPharma has a,unique story with ...
Cached Biology Technology:ShapeGrabber and Nikon Instruments Inc. Announce Distribution Agreement 2Cylex Announces Brad L. Stewart as President of the Company 2GeoPharma to Present at EdgeWater Research Partners Conference 2
(Date:8/28/2014)... 2014 Dyslexia, the most commonly diagnosed learning ... reading disability that occurs when the regions of ... normally. , The use of non-invasive functional neuroimaging ... disrupted in dyslexia. However, most prior work has ... regions, leaving a gap in our understanding of ...
(Date:8/28/2014)... northern California, and Alaska totaled 515 million board feet ... increase of more than 10 percent compared to the ... Northwest Research Station reported today. During this same period, ... 247 million board feet. , The total value of ... to $390 million in the same quarter, while the ...
(Date:8/27/2014)... Aug. 27, 2014  WaferGen Bio-systems, Inc. (NASDAQ: WGBS) ... underwritten public offering of units of common stock and ... gross proceeds of $20 million, prior to deducting underwriting ... Company.  The shares and warrants are immediately separable and ... sold in the offering consists of 2,000 shares of ...
Breaking Biology News(10 mins):Dyslexic readers have disrupted network connections in the brain 2West coast log exports up, lumber exports down in second quarter of 2014 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 2WaferGen Bio-Systems Announces Successful Completion of Public Offering Raising $20 Million 3
... to company, JERICHO, N.Y. and GUANGZHOU, China, ... SKI Engineering, jointly announced,that they have formed a ... and manufacturing capabilities., "I,m extremely excited about ... Basile, CEO of bioMETRX. "The former Sequiam East,s,engineering ...
... First identified in 1899, y-larvae have been one of ... one has ever found an adult of these puzzling ... leading generations of marine zoologists to wonder just what ... in BioMed Centrals open access journal, BMC Biology, reports ...
... the missing flu virus. When the flu isnt making people ... on Earth, it reappears in the appropriate season and starts ... Does it hibernate, lying dormant in a few people and ... the Northern hemisphere to the Southern hemisphere and back, following ...
Cached Biology News:bioMETRX Expands Engineering and Manufacturing Capabilities 2bioMETRX Expands Engineering and Manufacturing Capabilities 3Clue to mystery crustacean in parasite form 2Tracking influenza's every movement 2
... Forma Refrigerated Console Orbital Shakers combine ... ergonomics, unequalled programming power. The ... allowing the unit to run with ... HEPA filtration system reduces contamination. ...
... Transcriptase (RT) is an improved version of ... a DNA polymerase that synthesizes a complementary ... an RNA:DNA hybrid. This enzyme is genetically ... rather than a deletion in the RNase ...
... The Cellject Uno Electroporator is a ... producing optimum efficiencies in bacterial and ... selects one of two voltages and ... four mm cuvettes. On pressing the ...
... CGH Genomic Labeling Systems are a high-performance ... genomic DNA samples for array-based Comparative Genomic ... direct labeling formats, the BioPrime Plus Array ... solution to your genomic labeling needs. ...
Biology Products: